Download PDF
Klin Monbl Augenheilkd 2015; 232(4): 579-580
DOI: 10.1055/s-0035-1545749
Der interessante Fall
Georg Thieme Verlag KG Stuttgart · New York

Simultaneous Anterior and Posterior Segment Fluorescein Angiography in Sickle Cell Disease

Simultan-Fluoreszenzangiografie des vorderen und hinteren Augenabschnittes bei Sichelzellanamie
P. Kourti
Vitreoretinal Surgery Unit, Department of Ophthalmology, Jules Gonin Eye Hospital, Fondation Asile des Aveugles, University of Lausanne, Switzerland
,
J.-A. C. Pournaras
Vitreoretinal Surgery Unit, Department of Ophthalmology, Jules Gonin Eye Hospital, Fondation Asile des Aveugles, University of Lausanne, Switzerland
› Author Affiliations
Further Information

Publication History

Publication Date:
22 April 2015 (online)

Also available at
    Permissions and Reprints

Background

Ocular complications of sickle cell disease include anterior, posterior segment and orbital abnormalities and are secondary to tissue ischemia.Various types of sickling disorders such as SS, AS, SC and SThal could present ocular associations and therefore ophthalmic controls are part of the general screening procedures. Examination of patients with sickling hemoglobinopathies should begin in childhood and continue throughout life at annual intervals [1].

The spectrum of anterior segment manifestations is wide and includes conjonctival vessel alterations, iris depigmentation or atrophy [2], [3], anterior uveitis, spontaneous or traumatic hyphema and cataract [4].

Posterior segment findings comprise sickle cell retinopathy and optic atrophy [5].

In this article we report the clinical and angiographic findings obtained in two asymptomatic sisters by simultaneous anterior and posterior widefield imaging.

 

  • References

  • 1 Emerson GG, Lutty GA. Effects of sickle cell disease on the eye: clinical features and treatment. Hematol Oncol Clin N Am 2005; 19: 957-973
    CrossrefPubMedGoogle Scholar
  • 2 Galinos S, Rabb MF, Goldberg MF et al. Hemoglobin SC disease and iris atrophy. Am J Ophthalmol 1973; 75: 421-425
    CrossrefPubMedGoogle Scholar
  • 3 Chambers J, Puglisi J, Kernitsky R et al. Iris atrophy in hemoglobin SC disease. Am J Ophthalmol 1974; 77: 247-249
    CrossrefPubMedGoogle Scholar
  • 4 Lim JI. Ophthalmic manifestations of sickle cell disease: update of the latest findings. Curr Opin Ophthalmol 2012; 23: 533-536
    CrossrefPubMedGoogle Scholar
  • 5 Elaagouz M, Jyothi S, Gupta B et al. Sickle cell disease and the eye: old and new concepts. Surv Ophthalmol 2010; 55: 359-377
    CrossrefPubMedGoogle Scholar
  • 6 Pournaras CJ. Pathologies vasculaires oculaires. Masson: Société Française dʼOphtalmologie; 2008
    Google Scholar
  • 7 Acheson RW, Ford SM, Maude GH et al. Iris atrophy in sickle cell disease. Br J Ophthalmol 1986; 70: 516-521
    CrossrefPubMedGoogle Scholar
  • 8 Osafo-Kwaako A et al. Ocular manifestations of sickle cell disease at the Korle-Bu hospital, Accra, Ghana. Eur J Ophthalmol 2011; 21: 484-489
    CrossrefPubMedGoogle Scholar